SWL-1 Reverses Fluconazole Resistance in Candida albicans by Regulating the Glycolytic Pathway

Candida albicans is a ubiquitous clinical fungal pathogen. Prolonged use of the first-line antifungal agent fluconazole (FLC) has intensified fungal resistance and limited its effectiveness for the treatment of fungal infections. The combined administration of drugs has been extensively studied and...

Descripción completa

Detalles Bibliográficos
Autores principales: Li, Xiao-Ning, Zhang, Lu-Mei, Wang, Yuan-Yuan, Zhang, Yi, Jin, Ze-Hua, Li, Jun, Wang, Rui-Rui, Xiao, Wei-Lie
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2020
Materias:
Microbiology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7596347/
https://www.ncbi.nlm.nih.gov/pubmed/33178156
http://dx.doi.org/10.3389/fmicb.2020.572608

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7596347/
https://www.ncbi.nlm.nih.gov/pubmed/33178156
http://dx.doi.org/10.3389/fmicb.2020.572608

Ejemplares similares